Elimination of GGTA1, CMAH, β4GalNT2 and CIITA genes in pigs compromises human versus pig xenogeneic immune reactions

Abstract

Background: Pig organ xenotransplantation is a potential solution for the severe organ shortage in clinic, while immunogenic genes need to be eliminated to improve the immune compatibility between humans and pigs. Current knockout strategies are mainly aimed at the genes causing hyperacute immune rejection (HAR) that occurs in the first few hours while adaptive immune reactions orchestrated by CD4 T cell thereafter also cause graft failure, in which process the MHC II molecule plays critical roles.

Methods: Thus, we generate a 4-gene (GGTA1, CMAH, β4GalNT2, and CIITA) knockout pig by CRISPR/Cas9 and somatic cell nuclear transfer to compromise HAR and CD4 T cell reactions simultaneously.

Results: We successfully obtained 4KO piglets with deficiency in all alleles of genes, and at cellular and tissue levels. Additionally, the safety of our animals after gene editing was verified by using whole-genome sequencing and karyotyping. Piglets have survived for more than one year in the barrier, and also survived for more than 3 months in the conventional environment, suggesting that the piglets without MHC II can be raised in the barrier and then gradually mated in the conventional environment.

Conclusions: 4KO piglets have lower immunogenicity, are safe in genomic level, and are easier to breed than the model with both MHC I and II deletion.

Keywords

CD4 T cell / genetically edited pig / immune rejection / major histocompatibility complex II / xenotransplantation

References

[1] CooperDK, GoodAH, KorenE, et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol. 1993;1(3):198-205.

[2] LaiL, Kolber-Simonds D, ParkK-W, et al. Production of α-1, 3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science. 2002;295(5557):1089-1092.

[3] PhelpsCJ, KoikeC, VaughtTD, et al. Production of α1, 3-galactosyltransferase-deficient pigs. Science. 2003;299(5605):411-414.

[4] EstradaJL, Martens G, LiP, et al. Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes. Xenotransplantation. 2015;22(3):194-202.

[5] YoonS, LeeS, ParkC, et al. An efficacious transgenic strategy for triple knockout of Xeno-reactive antigen genes GGTA1, CMAH, and B4GALNT2 from Jeju native pigs. Vaccines (Basel). 2022;10(9):1503.

[6] ChenG, QianH, StarzlT, et al. Acute rejection is associated with antibodies to non-gal antigens in baboons using gal-knockout pig kidneys. Nat Med. 2005;11(12):1295-1298.

[7] LuT, YangB, WangR, Qin C. Xenotransplantation: current status in preclinical research. Front Immunol. 2020;10:3060.

[8] SykesM, SachsDH. Progress in xenotransplantation: overcoming immune barriers. Nat Rev Nephrol. 2022;18(12):745-761.

[9] KimSC, Mathews DV, BreedenCP, et al. Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion. Am J Transplant. 2019;19(8):2174-2185.

[10] HaraH, WittW, CrossleyT, et al. Human dominant-negative class II transactivator transgenic pigs – effect on the human anti-pig T-cell immune response and immune status. Immunology. 2013;140(1):39-46.

[11] IssaN, CosioFG, GloorJM, et al. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation. 2008;86(5):681-685.

[12] HammerSE, HoCS, AndoA, et al. Importance of the major histocompatibility complex (swine leukocyte antigen) in swine health and biomedical research. Annu Rev Anim Biosci. 2020;8:171-198.

[13] SakeHJ, Frenzel A, Lucas-HahnA, et al. Possible detrimental effects of beta-2-microglobulin knockout in pigs. Xenotransplantation. 2019;26(6):e12525.

[14] RenJ, YuD, WangJ, et al. Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver. Cell Biosci. 2022;12(1):26.

[15] ChangCH, Guerder S, HongSC, van EwijkW, Flavell RA. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 1996;4(2):167-178.

[16] WilliamsGS, MalinM, VremecD, et al. Mice lacking the transcription factor CIITA—a second look. Int Immunol. 1998;10(12):1957-1967.

[17] MartensGR, ReyesLM, ButlerJR, et al. Humoral reactivity of renal transplant-waitlisted patients to cells from GGTA1/CMAH/B4GalNT2, and SLA class I knockout pigs. Transplantation. 2017;101(4): e86-e92.

[18] LadowskiJM, ReyesLM, MartensGR, et al. Swine Leukocyte Antigen Class II Is a Xenoantigen. Transplantation. 2018;102(2):249-254.

[19] FuR, FangM, XuK, et al. Generation of GGTA1−/−β2M−/-CIITA−/− pigs using CRISPR/Cas9 technology to alleviate xenogeneic immune reactions. Transplantation. 2020;104(8):1566-1573.

[20] XuK, YuH, ChenS, et al. Production of triple-gene (GGTA1, B2M and CIITA)-modified donor pigs for xenotransplantation. Front Vet Sci. 2022;9:848833.

RIGHTS & PERMISSIONS

2024 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.